课题基金 / 基金详情

Improving the Efficiency of Gene Targeting Using TAL Effector Nucleases

Improving the Efficiency of Gene Targeting Using TAL Effector Nucleases
使用 TAL 效应核酸酶提高基因打靶的效率
批准号:
8609491
负责人:
Shengdar Tsai
金额:
$5.51万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-02-01 至 2015-01-31

项目摘要

项目成果

Shengdar Tsai的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The long-term objective of this proposal is to develop broadly applicable methods to utilize engineered nucleases to facilitate gene targeting in human somatic and pluripotent cells. The specific aims are: 1) to enhance our ability to genetically engineer all types of genetic modifications by homologous recombination using engineered nucleases (TAL effector nucleases or TALENs) in human somatic and pluripotent cells and 2) to improve our ability to use TALEN-derived nicking enzymes for homologous recombination. This proposal will leverage a high-throughput assembly method for creating engineered TALENs and apply it to the genetic engineering of human cell lines. Successful development of the proposed methods for introducing small insertions and single-base modifications to the human genome will enhance the ability to systematically investigate the relationship between human gene variation and function and enable genetic manipulations that have been previously limited to mouse model systems.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Sensitive, unbiased, high-throughput, cellular GUIDE-seq-2 genome-wide activity assay for therapeutic genome editing INDs
Ultra-sensitive, unbiased, high-throughput, biochemical CHANGE-seq genome-wide activity and gRNA sequencing assays for therapeutic genome editing INDs
A novel human T-cell platform to define biological effects of genome editing
A novel human T-cell platform to define biological effects of genome editing
海外基金